Trials / Unknown
UnknownNCT02721264
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis: A Randomized Control Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (estimated)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients of NASH (Non Alcoholic Steatohepatitis) cirrhosis with current or prior histological evidence of steatosis or steatohepatitis admitted under the Department of Hepatology at Institute of Liver and Biliary Sciences, who meet the inclusion criteria and who provide informed consent will be included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fecal Microbiota Transplant | |
| OTHER | Standard Medical Treatment |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2018-06-30
- Completion
- 2018-06-30
- First posted
- 2016-03-29
- Last updated
- 2018-02-15
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02721264. Inclusion in this directory is not an endorsement.